Advent Capital Management Sarepta Therapeutics, Inc. Transaction History
Advent Capital Management
- $71.1 Million
- Q1 2024
A detailed history of Advent Capital Management transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Advent Capital Management holds 20,000 shares of SRPT stock, worth $3.03 Million. This represents 3.64% of its overall portfolio holdings.
Number of Shares
20,000
Previous 14,000
42.86%
Holding current value
$3.03 Million
Previous $1.35 Million
91.78%
% of portfolio
3.64%
Previous 1.6%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.33 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$904 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$742 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$731 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$659 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $13.3B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...